These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2183339)

  • 1. [Adjuvant medical treatment].
    Plagne R; Chollet P; Legros M; Cure H; Ferrière JP; Bignon YJ
    Rev Prat; 1990 Apr; 40(10):905-8. PubMed ID: 2183339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant therapy in early breast cancer.
    Chittoor SR; Swain SM
    Am Fam Physician; 1991 Aug; 44(2):453-62. PubMed ID: 1858602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant therapy in breast cancer.
    Robert NJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast Group.
    Morales L; Canney P; Dyczka J; Rutgers E; Coleman R; Cufer T; Welnicka-Jaskiewicz M; Nortier J; Bogaerts J; Therasse P; Paridaens R; ;
    Eur J Cancer; 2007 Jan; 43(2):331-40. PubMed ID: 17134892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
    Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
    Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Breast carcinoma--adjuvant chemo- and hormone therapy].
    Fey MF
    Ther Umsch; 1998 Jul; 55(7):413-4. PubMed ID: 9702106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
    Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions].
    Goldhirsch A; Neuenschwander H; Castiglione M; Senn HJ; Cavalli F
    Schweiz Med Wochenschr; 1990 Nov; 120(47):1771-83. PubMed ID: 2255883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant hormonal therapy for premenopausal women with breast cancer.
    Brown RJ; Davidson NE
    Semin Oncol; 2006 Dec; 33(6):657-63. PubMed ID: 17145345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Questions and answers on adjuvant systemic therapy in breast carcinoma].
    Fey MF; Castiglione-Gertsch M
    Ther Umsch; 1996 Nov; 53(11):839-46. PubMed ID: 8984689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
    Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
    Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Respective indications for hormone therapy, induction chemotherapy and adjuvant chemotherapy in breast cancer without clinically discernable distant metastases].
    Roy JA; Piccart MJ
    Rev Med Brux; 1995; 16(4):242-4. PubMed ID: 7481234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal manipulation in the adjuvant treatment of breast cancer.
    Honig SF; Swain SM
    Important Adv Oncol; 1993; ():103-23. PubMed ID: 8505047
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chemo-endocrine therapy of advanced breast cancer].
    Nomura Y
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3214-20. PubMed ID: 2973769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic adjuvant therapy of breast cancer.
    O'Connell J
    Conn Med; 1999 Jan; 63(1):29-33. PubMed ID: 10071436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
    Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant treatment of breast cancer.
    Akerley WL
    R I Med; 1995 Sep; 78(9):250-3. PubMed ID: 7579720
    [No Abstract]   [Full Text] [Related]  

  • 18. [Progress in breast cancer chemo-endocrine therapy from the survival standpoint].
    Nomura Y
    Gan To Kagaku Ryoho; 1995 May; 22(6):726-31. PubMed ID: 7755380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing "the soft option": trials of adjuvant endocrine therapy for the primary treatment of breast cancer.
    Ebbs SR; Baum M
    Isr J Med Sci; 1988; 24(9-10):552-6. PubMed ID: 3060445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials.
    Noguchi S; Koyama H; Uchino J; Abe R; Miura S; Sugimachi K; Akazawa K; Abe O
    J Clin Oncol; 2005 Apr; 23(10):2172-84. PubMed ID: 15800310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.